Pfizer to seek approval for RSV vaccine for people as young as 18
By John Bonifield, CNN (CNN) — An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. The company said it would submit the information to the US Food and Drug Administration for potential expansion
Continue Reading